Ihuman Cost Of Revenue vs Tax Provision Analysis
IH Stock | USD 1.65 0.01 0.61% |
Ihuman financial indicator trend analysis is infinitely more than just investigating Ihuman Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ihuman Inc is a good investment. Please check the relationship between Ihuman Cost Of Revenue and its Tax Provision accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Cost Of Revenue vs Tax Provision
Cost Of Revenue vs Tax Provision Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ihuman Inc Cost Of Revenue account and Tax Provision. At this time, the significance of the direction appears to have strong relationship.
The correlation between Ihuman's Cost Of Revenue and Tax Provision is 0.7. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Tax Provision in the same time period over historical financial statements of Ihuman Inc, assuming nothing else is changed. The correlation between historical values of Ihuman's Cost Of Revenue and Tax Provision is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Ihuman Inc are associated (or correlated) with its Tax Provision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Tax Provision has no effect on the direction of Cost Of Revenue i.e., Ihuman's Cost Of Revenue and Tax Provision go up and down completely randomly.
Correlation Coefficient | 0.7 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Cost Of Revenue
Cost of Revenue is found on Ihuman Inc income statement and represents the costs associated with goods and services Ihuman provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Most indicators from Ihuman's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ihuman Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, Ihuman's Enterprise Value Multiple is increasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 660.6M | 691.2M | 721.3M | 483.8M | Total Revenue | 944.7M | 985.5M | 1.0B | 702.3M |
Ihuman fundamental ratios Correlations
Click cells to compare fundamentals
Ihuman Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ihuman fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 168.3M | 1.0B | 1.1B | 1.3B | 1.5B | 945.7M | |
Other Current Liab | 880K | 90.1M | 104.7M | 118.8M | 438.0M | 459.9M | |
Total Current Liabilities | 182.8M | 399.2M | 482.9M | 561.1M | 490.8M | 410.5M | |
Total Stockholder Equity | (14.4M) | 642.7M | 608.4M | 769.5M | 957.8M | 531.7M | |
Property Plant And Equipment Net | 2.5M | 12.9M | 50.5M | 22.0M | 9.8M | 18.0M | |
Current Deferred Revenue | 71.8M | 268.6M | 303.0M | 379.1M | 318.6M | 251.0M | |
Net Debt | (104.9M) | (855.1M) | (821.1M) | (1.0B) | (1.2B) | (1.1B) | |
Retained Earnings | (348.5M) | (386.0M) | (423.0M) | (321.2M) | (140.5M) | (147.5M) | |
Accounts Payable | 10.3M | 21.6M | 30.5M | 24.2M | 22.1M | 22.3M | |
Cash | 104.9M | 861.7M | 855.4M | 1.0B | 1.2B | 750.2M | |
Non Current Assets Total | 5.3M | 25.5M | 85.6M | 79.6M | 68.1M | 48.6M | |
Non Currrent Assets Other | 2.7M | 784K | 7.8M | 6.4M | 8.7M | 4.9M | |
Other Assets | 2.7M | 784K | 7.8M | 6.4M | 7.4M | 4.0M | |
Cash And Short Term Investments | 104.9M | 861.7M | 855.4M | 1.0B | 1.2B | 750.2M | |
Net Receivables | 21.0M | 78.3M | 59.0M | 81.9M | 62.6M | 58.0M | |
Liabilities And Stockholders Equity | 168.3M | 1.0B | 1.1B | 1.3B | 1.5B | 945.7M | |
Non Current Liabilities Total | 82.1M | 5.1M | 9.6M | 2.9M | 1.9M | 1.8M | |
Capital Surpluse | 213.1M | 1.1B | 1.1B | 1.1B | 1.2B | 751.9M | |
Inventory | 20.7M | 16.9M | 28.1M | 19.1M | 16.5M | 17.4M | |
Other Current Assets | 574K | 64.6M | 72.9M | 102.8M | 89.5M | 60.9M | |
Other Stockholder Equity | 333.9M | 1.1B | 1.1B | 1.1B | 1.1B | 844.0M | |
Total Liab | 182.8M | 404.3M | 492.5M | 563.9M | 492.7M | 414.1M | |
Net Invested Capital | (14.4M) | 642.7M | 608.4M | 769.5M | 957.8M | 531.7M | |
Total Current Assets | 163.1M | 1.0B | 1.0B | 1.3B | 1.4B | 897.1M | |
Accumulated Other Comprehensive Income | 0.0 | (21.9M) | (34.7M) | 18.5M | 26.1M | 27.4M | |
Cash And Equivalents | 104.9M | 861.7M | 855.4M | 1.0B | 1.2B | 633.2M | |
Net Working Capital | (19.7M) | 622.2M | 532.3M | 692.7M | 891.7M | 486.6M | |
Short Term Debt | 99.8M | 1.5M | 24.7M | 6.1M | 1.9M | 1.8M | |
Intangible Assets | 103K | 11.8M | 27.3M | 24.9M | 23.2M | 16.0M | |
Property Plant Equipment | 2.5M | 12.9M | 50.5M | 22.0M | 25.3M | 19.5M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Earnings Share (0.16) | Revenue Per Share 18.263 | Quarterly Revenue Growth (0.11) | Return On Assets 0.0456 |
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.